Mannitol pharmacokinetics and serum osmolality in dogs and humans
- PMID: 3080582
Mannitol pharmacokinetics and serum osmolality in dogs and humans
Erratum in
- J Pharmacol Exp Ther 1986 Dec;239(3):959
Abstract
The relationship between mannitol pharmacokinetics and changes in serum osmolality were studied in dogs and humans. Four human subjects each received between 0.5 and 0.7 g/kg of mannitol as an i.v. infusion given over 15 min. Intravenous bolus doses of 0.5, 1.0 and 1.5 g/kg were given to each of five animals. Serial determinations of serum osmolality and serum mannitol concentrations were then performed. Mannitol disposition was best described using a biexponential equation and assuming a two-compartment, open model with elimination from the central compartment. For human subjects, the mean (+/- S.D.) distribution half-life was 2.11 +/- 2.67 min and the elimination half-life was 71.15 +/- 27.02 min. The volume of distribution was 0.47 +/- 0.50 liters/kg and total body clearance was 7.15 +/- 10.23 ml X min-1 X kg-1. The disposition of mannitol in dogs is similar to that observed in humans. Mannitol clearance was independent of dose whereas the central compartment volume was significantly larger (P less than .005) in animals receiving the 1.5-g/kg dose. The volume change is probably due to a rapid, uncompensated shift of water from intracellular to extracellular space. There was a strong positive correlation (r = 0.90) between mannitol concentration and serum osmolality changes. However, neither maximum serum mannitol concentration nor maximum serum osmolality increased proportionately with dose. Only the 1.5-g/kg dose produced a sustained elevation of serum osmolality, confirming that larger doses are more likely to result in prolonged hypertonic dehydration.
Similar articles
-
[Pharmacokinetic basis of mannitol administration in the treatment of raised ICP].No Shinkei Geka. 1991 Jul;19(7):619-24. No Shinkei Geka. 1991. PMID: 1909772 Japanese.
-
Hypertonic extracellular expansion in anuria.Miner Electrolyte Metab. 1983 Mar-Apr;9(2):99-107. Miner Electrolyte Metab. 1983. PMID: 6405148
-
[Effect of NIK-242 inj. (20% erythritol) on intracranial pressure in dogs with acute obstructive hydrocephalus].No To Shinkei. 1990 Jan;42(1):79-85. No To Shinkei. 1990. PMID: 2110812 Japanese.
-
[Hypertonic solutions and intracranial pressure].Schweiz Med Wochenschr. 1996 Sep 28;126(39):1635-43. Schweiz Med Wochenschr. 1996. PMID: 8927967 Review. French.
-
The effect of high-dose mannitol on serum and urine electrolytes and osmolality in neurosurgical patients.Can J Anaesth. 1987 Sep;34(5):442-6. doi: 10.1007/BF03014345. Can J Anaesth. 1987. PMID: 3117392 Review.
Cited by
-
Pharmacokinetics of oral mannitol for bowel preparation for colonoscopy.Clin Transl Sci. 2022 Oct;15(10):2448-2457. doi: 10.1111/cts.13373. Epub 2022 Aug 8. Clin Transl Sci. 2022. PMID: 37074807 Free PMC article. Clinical Trial.
-
Sequential changes in urine production, glomerular filtration rate, and electrolyte excretion after mannitol administration.J Vet Intern Med. 2019 May;33(3):1362-1367. doi: 10.1111/jvim.15490. Epub 2019 Mar 30. J Vet Intern Med. 2019. PMID: 30927388 Free PMC article.
-
Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.Exp Neurol. 2008 Apr;210(2):645-55. doi: 10.1016/j.expneurol.2007.12.019. Epub 2008 Jan 5. Exp Neurol. 2008. PMID: 18291370 Free PMC article.
-
Variation in osmotic response to sustained mannitol administration.Neurocrit Care. 2008;9(2):204-9. doi: 10.1007/s12028-008-9118-3. Neurocrit Care. 2008. PMID: 18563637 Free PMC article.
-
Mannitol for prevention of acute kidney injury after liver transplantation: a randomized controlled trial.BMC Anesthesiol. 2022 Dec 19;22(1):393. doi: 10.1186/s12871-022-01936-7. BMC Anesthesiol. 2022. PMID: 36536282 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous